• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ULTRASCORE FOCUSED FORCE PTA BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ULTRASCORE FOCUSED FORCE PTA BALLOON Back to Search Results
Model Number US35130612
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Vascular Dissection (3160)
Date of Event 10/18/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
No medical images have been made available to the manufacturer.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.Medical records review: the patient with history of peripheral vascular disease with claudication was scheduled for peripheral vascular intervention.The right groin was accessed and the catheter was advanced to the left femoral artery.A left femoral angiogram with runoff was performed which demonstrated a 12cm lesion with 80% stenosis in the distal superficial femoral artery.The lesion was crossed and atherectomy was performed with 70% residual stenosis.Balloon angioplasty was performed with a scoring balloon.Repeat angiography demonstrated minor non-flow limiting dissection which was stented because of the ulcerative nature of the plaque.Repeat imaging demonstrated 0% stenosis.The sheath was removed and hemostasis was achieved.(expiration date: 03/2020), (04/2018).
 
Event or Problem Description
It was reported through the results of a clinical trial, that during an angioplasty procedure in the left mid/distal superficial femoral artery with a focused force percutaneous transluminal angioplasty (pta) balloon, imaging demonstrated dissection which resulted in stent placement.Following stent placement, imaging no longer demonstrate the dissection.The current patient status was not provided.
 
Event or Problem Description
It was reported through the results of a clinical trial, that during an angioplasty procedure in the left mid/distal superficial femoral artery with a focused force percutaneous transluminal angioplasty (pta) balloon, imaging demonstrated dissection which resulted in stent placement.Following stent placement, imaging no longer demonstrate the dissection.The current patient status was not provided.
 
Additional Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process, and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.This is the only complaint reported to date for this lot number and failure mode.Investigation summary: complaint reported to date for this lot number and failure mode.The device was not returned, but medical records were provided.Based on the medical records, dissection following the use of an ultrascore pta balloon can be confirmed.However, the investigation is inconclusive, as no objective evidence has been provided to confirm an alleged deficiency with the device.Based upon the available information, the definitive root cause is unknown.Labeling review: the review of the ifu (instructions for use), indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.(expiration date: 03/2020).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRASCORE FOCUSED FORCE PTA BALLOON
Common Device Name
FOCUSED FORCE PTA BALLOON
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key8161617
Report Number2020394-2018-02200
Device Sequence Number2009969
Product Code PNO
UDI-Device Identifier00801741116889
UDI-Public(01)00801741116889
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
K172571
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,study
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 01/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberUS35130612
Device Catalogue NumberUS35130612
Device Lot NumberGFCN4125
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 11/16/2018
Supplement Date Received by Manufacturer01/17/2019
Initial Report FDA Received Date12/13/2018
Supplement Report FDA Received Date01/31/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age58 YR
Patient Weight142
-
-